HY-10053-10mg
|
MedChemexpress LLC
|
Maropitant [CAS 147116-67-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-10053-100mg
|
MedChemexpress LLC
|
Maropitant [CAS 147116-67-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-10053-25mg
|
MedChemexpress LLC
|
Maropitant [CAS 147116-67-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-10053-5mg
|
MedChemexpress LLC
|
Maropitant [CAS 147116-67-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-10053-50mg
|
MedChemexpress LLC
|
Maropitant [CAS 147116-67-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-100609-10mg
|
MedChemexpress LLC
|
4-P-PDOT [CAS 134865-74-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-100609-100mg
|
MedChemexpress LLC
|
4-P-PDOT [CAS 134865-74-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-100609-5mg
|
MedChemexpress LLC
|
4-P-PDOT [CAS 134865-74-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-100609-50mg
|
MedChemexpress LLC
|
4-P-PDOT [CAS 134865-74-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-100750-10mg
|
MedChemexpress LLC
|
Norverapamil (hydrochloride) [CAS 67812-42-4]
|
|
COVID-19-immunoregulation
|
|
HY-100750-2mg
|
MedChemexpress LLC
|
Norverapamil (hydrochloride) [CAS 67812-42-4]
|
|
COVID-19-immunoregulation
|
|
HY-100750-25mg
|
MedChemexpress LLC
|
Norverapamil (hydrochloride) [CAS 67812-42-4]
|
|
COVID-19-immunoregulation
|
|
HY-100750-5mg
|
MedChemexpress LLC
|
Norverapamil (hydrochloride) [CAS 67812-42-4]
|
|
COVID-19-immunoregulation
|
|
HY-101494-1mg
|
MedChemexpress LLC
|
TeMu terkib [CAS 1951483-29-6]
|
|
Cancer-Kinase/protease
|
|
HY-101494-10mg
|
MedChemexpress LLC
|
TeMu terkib [CAS 1951483-29-6]
|
|
Cancer-Kinase/protease
|
|
HY-101494-100mg
|
MedChemexpress LLC
|
TeMu terkib [CAS 1951483-29-6]
|
|
Cancer-Kinase/protease
|
|
HY-101494-5mg
|
MedChemexpress LLC
|
TeMu terkib [CAS 1951483-29-6]
|
|
Cancer-Kinase/protease
|
|
HY-101494-50mg
|
MedChemexpress LLC
|
TeMu terkib [CAS 1951483-29-6]
|
|
Cancer-Kinase/protease
|
|
HY-101511-1mg
|
MedChemexpress LLC
|
TTT-28 [CAS 1609138-51-3]
|
|
Cancer-programmed cell death
|
|
HY-101511-10mg
|
MedChemexpress LLC
|
TTT-28 [CAS 1609138-51-3]
|
|
Cancer-programmed cell death
|
|
HY-101511-100mg
|
MedChemexpress LLC
|
TTT-28 [CAS 1609138-51-3]
|
|
Cancer-programmed cell death
|
|
HY-101511-25mg
|
MedChemexpress LLC
|
TTT-28 [CAS 1609138-51-3]
|
|
Cancer-programmed cell death
|
|
HY-101511-5mg
|
MedChemexpress LLC
|
TTT-28 [CAS 1609138-51-3]
|
|
Cancer-programmed cell death
|
|
HY-101511-50mg
|
MedChemexpress LLC
|
TTT-28 [CAS 1609138-51-3]
|
|
Cancer-programmed cell death
|
|
HY-101861-10mg
|
MedChemexpress LLC
|
Miridesap [CAS 224624-80-0]
|
|
Neuroscience-Neuromodulation
|
|